212 related articles for article (PubMed ID: 36815785)
1. Critical Residues Involved in the Coassembly of L1 and L2 Capsid Proteins of Human Papillomavirus 16.
Chen J; Wang D; Wang Z; Wu K; Wei S; Chi X; Qian C; Xu Y; Zhou L; Li Y; Zhang S; Li T; Kong Z; Wang Y; Zheng Q; Yu H; Zhao Q; Zhang J; Xia N; Li S; Gu Y
J Virol; 2023 Mar; 97(3):e0181922. PubMed ID: 36815785
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of Human Papillomavirus Type 16 L2 Contributes to Efficient Virus Infectious Entry.
Broniarczyk J; Massimi P; Pim D; Bergant Marušič M; Myers MP; Garcea RL; Banks L
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996086
[TBL] [Abstract][Full Text] [Related]
3. Efficient Inhibition of Human Papillomavirus Infection by L2 Minor Capsid-Derived Lipopeptide.
Yan H; Foo SS; Chen W; Yoo JS; Shin WJ; Wu C; Jung JU
mBio; 2019 Aug; 10(4):. PubMed ID: 31387913
[TBL] [Abstract][Full Text] [Related]
4. Interactions between papillomavirus L1 and L2 capsid proteins.
Finnen RL; Erickson KD; Chen XS; Garcea RL
J Virol; 2003 Apr; 77(8):4818-26. PubMed ID: 12663788
[TBL] [Abstract][Full Text] [Related]
5. L2, the minor capsid protein of papillomavirus.
Wang JW; Roden RB
Virology; 2013 Oct; 445(1-2):175-86. PubMed ID: 23689062
[TBL] [Abstract][Full Text] [Related]
6. Arrangement of L2 within the papillomavirus capsid.
Buck CB; Cheng N; Thompson CD; Lowy DR; Steven AC; Schiller JT; Trus BL
J Virol; 2008 Jun; 82(11):5190-7. PubMed ID: 18367526
[TBL] [Abstract][Full Text] [Related]
7. Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens.
Trevisan A; Candeias JMG; Thomann P; Villa LL; Franco EL; Trottier H; The Ludwig-McGill Study Group
J Med Microbiol; 2020 Jul; 69(7):960-970. PubMed ID: 32510304
[No Abstract] [Full Text] [Related]
8. The Cytoskeletal Adaptor Obscurin-Like 1 Interacts with the Human Papillomavirus 16 (HPV16) Capsid Protein L2 and Is Required for HPV16 Endocytosis.
Wüstenhagen E; Hampe L; Boukhallouk F; Schneider MA; Spoden GA; Negwer I; Koynov K; Kast WM; Florin L
J Virol; 2016 Dec; 90(23):10629-10641. PubMed ID: 27654294
[TBL] [Abstract][Full Text] [Related]
9. Human Papillomavirus Minor Capsid Protein L2 Mediates Intracellular Trafficking into and Passage beyond the Endoplasmic Reticulum.
Morante AV; Baboolal DD; Simon X; Pan EC; Meneses PI
Microbiol Spectr; 2022 Jun; 10(3):e0150522. PubMed ID: 35608352
[TBL] [Abstract][Full Text] [Related]
10. Cyclophilins facilitate dissociation of the human papillomavirus type 16 capsid protein L1 from the L2/DNA complex following virus entry.
Bienkowska-Haba M; Williams C; Kim SM; Garcea RL; Sapp M
J Virol; 2012 Sep; 86(18):9875-87. PubMed ID: 22761365
[TBL] [Abstract][Full Text] [Related]
11. The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection.
Woodham AW; Da Silva DM; Skeate JG; Raff AB; Ambroso MR; Brand HE; Isas JM; Langen R; Kast WM
PLoS One; 2012; 7(8):e43519. PubMed ID: 22927980
[TBL] [Abstract][Full Text] [Related]
12. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
[TBL] [Abstract][Full Text] [Related]
13. Genetic variability in L1 and L2 genes of HPV-16 and HPV-58 in Southwest China.
Yue Y; Yang H; Wu K; Yang L; Chen J; Huang X; Pan Y; Ruan Y; Zhao Y; Shi X; Sun Q; Li Q
PLoS One; 2013; 8(1):e55204. PubMed ID: 23372836
[TBL] [Abstract][Full Text] [Related]
14. Mutation Profile of HPV16 L1 and L2 Genes in Different Geographic Areas.
Tsakogiannis D; Nikolaidis M; Zagouri F; Zografos E; Kottaridi C; Kyriakopoulou Z; Tzioga L; Markoulatos P; Amoutzias GD; Bletsa G
Viruses; 2022 Dec; 15(1):. PubMed ID: 36680181
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Assessment of the Antigenic Impact of Human Papillomavirus Lineage Variation on Recognition by Neutralizing Monoclonal Antibodies Raised against Lineage A Major Capsid Proteins of Vaccine-Related Genotypes.
Godi A; Boampong D; Elegunde B; Panwar K; Fleury M; Li S; Zhao Q; Xia N; Christensen ND; Beddows S
J Virol; 2020 Nov; 94(24):. PubMed ID: 32967963
[TBL] [Abstract][Full Text] [Related]
16. High resolution cryo EM analysis of HPV16 identifies minor structural protein L2 and describes capsid flexibility.
Goetschius DJ; Hartmann SR; Subramanian S; Bator CM; Christensen ND; Hafenstein SL
Sci Rep; 2021 Feb; 11(1):3498. PubMed ID: 33568731
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus type 16 minor capsid protein l2 N-terminal region containing a common neutralization epitope binds to the cell surface and enters the cytoplasm.
Kawana Y; Kawana K; Yoshikawa H; Taketani Y; Yoshiike K; Kanda T
J Virol; 2001 Mar; 75(5):2331-6. PubMed ID: 11160736
[TBL] [Abstract][Full Text] [Related]
18. Interferon Gamma Prevents Infectious Entry of Human Papillomavirus 16 via an L2-Dependent Mechanism.
Day PM; Thompson CD; Lowy DR; Schiller JT
J Virol; 2017 May; 91(10):. PubMed ID: 28250129
[TBL] [Abstract][Full Text] [Related]
19. In Silico Design and Immunological Studies of Two Novel Multiepitope DNA-Based Vaccine Candidates Against High-Risk Human Papillomaviruses.
Kayyal M; Bolhassani A; Noormohammadi Z; Sadeghizadeh M
Mol Biotechnol; 2021 Dec; 63(12):1192-1222. PubMed ID: 34308516
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus 16 minor capsid protein L2 helps capsomeres assemble independently of intercapsomeric disulfide bonding.
Ishii Y; Ozaki S; Tanaka K; Kanda T
Virus Genes; 2005 Dec; 31(3):321-8. PubMed ID: 16175337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
